Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Oct 6;301(6755):783–787. doi: 10.1136/bmj.301.6755.783

Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy.

R E Ryder 1, D R Owens 1, T M Hayes 1, M A Ghatei 1, S R Bloom 1
PMCID: PMC1663909  PMID: 2224265

Abstract

OBJECTIVE--To examine the traditional view that unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation in insulin dependent diabetes mellitus are manifestations of autonomic neuropathy. DESIGN--Perspective assessment of unawareness of hypoglycaemia and detailed assessment of autonomic neuropathy in patients with insulin dependent diabetes according to the adequacy of their hypoglycaemic counterregulation. SETTING--One routine diabetic unit in a university teaching hospital. PATIENTS--23 Patients aged 21-52 with insulin dependent diabetes mellitus (seven with symptoms suggesting autonomic neuropathy, nine with a serious clinical problem with hypoglycaemia, and seven without symptoms of autonomic neuropathy and without problems with hypoglycaemia) and 10 controls with a similar age distribution, without a personal or family history of diabetes. MAIN OUTCOME MEASURES--Presence of autonomic neuropathy as assessed with a test of the longest sympathetic fibres (acetylcholine sweatspot test), a pupil test, and a battery of seven cardiovascular autonomic function tests; adequacy of hypoglycaemic glucose counterregulation during a 40 mU/kg/h insulin infusion test; history of unawareness of hypoglycaemia; and response of plasma pancreatic polypeptide during hypoglycaemia, which depends on an intact and responding autonomic innervation of the pancreas. RESULTS--There was little evidence of autonomic neuropathy in either the 12 diabetic patients with a history of unawareness of hypoglycaemia or the seven patients with inadequate hypoglycaemic counterregulation. By contrast, in all seven patients with clear evidence of autonomic neuropathy there was no history of unawareness of hypoglycaemia and in six out of seven there was adequate hypoglycaemic counterregulation. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation were significantly associated (p less than 0.01). The response of plasma pancreatic polypeptide in the diabetic patients with adequate counterregulation but without autonomic neuropathy was not significantly different from that of the controls (change in plasma pancreatic polypeptide 226.8 v 414 pmol/l). The patients with autonomic neuropathy had a negligible plasma pancreatic polypeptide response (3.7 pmol/l), but this response was also blunted in the patients with inadequate hypoglycaemic counterregulation (72.4 pmol/l) compared with that of the controls (p less than 0.05). CONCLUSIONS--Unawareness of hypoglycaemia and inadequate glucose counterregulation during hypoglycaemia are related to each other but are not due to autonomic neuropathy. The blunted plasma pancreatic polypeptide responses of the patients with inadequate hypoglycaemic counterregulation may reflect diminished autonomic activity consequent upon reduced responsiveness of a central glucoregulatory centre, rather than classical autonomic neuropathy.

Full text

PDF
783

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amiel S. A., Tamborlane W. V., Simonson D. C., Sherwin R. S. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med. 1987 May 28;316(22):1376–1383. doi: 10.1056/NEJM198705283162205. [DOI] [PubMed] [Google Scholar]
  2. Boden G., Reichard G. A., Jr, Hoeldtke R. D., Rezvani I., Owen O. E. Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. N Engl J Med. 1981 Nov 12;305(20):1200–1205. doi: 10.1056/NEJM198111123052007. [DOI] [PubMed] [Google Scholar]
  3. Bolli G., de Feo P., Compagnucci P., Cartechini M. G., Angeletti G., Santeusanio F., Brunetti P., Gerich J. E. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes. 1983 Feb;32(2):134–141. doi: 10.2337/diab.32.2.134. [DOI] [PubMed] [Google Scholar]
  4. Boyle P. J., Schwartz N. S., Shah S. D., Clutter W. E., Cryer P. E. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med. 1988 Jun 9;318(23):1487–1492. doi: 10.1056/NEJM198806093182302. [DOI] [PubMed] [Google Scholar]
  5. Campbell L. V., Kraegen E. W., Lazarus L. Defective blood glucose counter-regulation in diabetics is a selective form of autonomic neuropathy. Br Med J. 1977 Dec 10;2(6101):1527–1529. doi: 10.1136/bmj.2.6101.1527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cryer P. E., Gerich J. E. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. N Engl J Med. 1985 Jul 25;313(4):232–241. doi: 10.1056/NEJM198507253130405. [DOI] [PubMed] [Google Scholar]
  7. Cryer P. E., Gerich J. E. Relevance of glucose counterregulatory systems to patients with diabetes: critical roles of glucagon and epinephrine. Diabetes Care. 1983 Jan-Feb;6(1):95–99. doi: 10.2337/diacare.6.1.95. [DOI] [PubMed] [Google Scholar]
  8. Cryer P. E. The metabolic impact of autonomic neuropathy in insulin-dependent diabetes mellitus. Arch Intern Med. 1986 Nov;146(11):2127–2129. [PubMed] [Google Scholar]
  9. DeFronzo R. A., Hendler R., Christensen N. Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration. Diabetes. 1980 Feb;29(2):125–131. doi: 10.2337/diab.29.2.125. [DOI] [PubMed] [Google Scholar]
  10. Ewing D. J., Borsey D. Q., Bellavere F., Clarke B. F. Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation. Diabetologia. 1981 Jul;21(1):18–24. doi: 10.1007/BF03216217. [DOI] [PubMed] [Google Scholar]
  11. Ewing D. J., Clarke B. F. Autonomic neuropathy: its diagnosis and prognosis. Clin Endocrinol Metab. 1986 Nov;15(4):855–888. doi: 10.1016/s0300-595x(86)80078-0. [DOI] [PubMed] [Google Scholar]
  12. Ewing D. J., Clarke B. F. Diabetic autonomic neuropathy: present insights and future prospects. Diabetes Care. 1986 Nov-Dec;9(6):648–665. doi: 10.2337/diacare.9.6.648. [DOI] [PubMed] [Google Scholar]
  13. Ewing D. J., Clarke B. F. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed) 1982 Oct 2;285(6346):916–918. doi: 10.1136/bmj.285.6346.916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Faber O. K., Binder C. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. Diabetes. 1977 Jul;26(7):605–610. doi: 10.2337/diab.26.7.605. [DOI] [PubMed] [Google Scholar]
  15. Heding L. G. Radioimmunological determination of human C-peptide in serum. Diabetologia. 1975 Dec;11(6):541–548. doi: 10.1007/BF01222104. [DOI] [PubMed] [Google Scholar]
  16. Heller S. R., Macdonald I. A., Herbert M., Tattersall R. B. Influence of sympathetic nervous system on hypoglycaemic warning symptoms. Lancet. 1987 Aug 15;2(8555):359–363. doi: 10.1016/s0140-6736(87)92382-8. [DOI] [PubMed] [Google Scholar]
  17. Hilsted J., Madsbad S., Krarup T., Sestoft L., Christensen N. J., Tronier B., Galbo H. Hormonal, metabolic, and cardiovascular responses to hypoglycemia in diabetic autonomic neuropathy. Diabetes. 1981 Aug;30(8):626–633. doi: 10.2337/diab.30.8.626. [DOI] [PubMed] [Google Scholar]
  18. Himsworth R. L. Hypothalamic control of adrenaline secretion in response to insufficient glucose. J Physiol. 1970 Feb;206(2):411–417. doi: 10.1113/jphysiol.1970.sp009021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hoeldtke R. D., Boden G., Shuman C. R., Owen O. E. Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med. 1982 Apr;96(4):459–462. doi: 10.7326/0003-4819-96-4-459. [DOI] [PubMed] [Google Scholar]
  20. Kleinbaum J., Shamoon H. Impaired counterregulation of hypoglycemia in insulin-dependent diabetes mellitus. Diabetes. 1983 Jun;32(6):493–498. doi: 10.2337/diab.32.6.493. [DOI] [PubMed] [Google Scholar]
  21. Polonsky K. S., Herold K. C., Gilden J. L., Bergenstal R. M., Fang V. S., Moossa A. R., Jaspan J. B. Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes. Diabetes. 1984 Nov;33(11):1112–1119. doi: 10.2337/diab.33.11.1112. [DOI] [PubMed] [Google Scholar]
  22. Ryder R. E., Marshall R., Johnson K., Ryder A. P., Owens D. R., Hayes T. M. Acetylcholine sweatspot test for autonomic denervation. Lancet. 1988 Jun 11;1(8598):1303–1305. doi: 10.1016/s0140-6736(88)92120-4. [DOI] [PubMed] [Google Scholar]
  23. Ryder R. E., Vora J. P., Atiea J. A., Owens D. R., Hayes T. M., Young S. Possible new method to improve detection of diabetic retinopathy: Polaroid non-mydriatic retinal photography. Br Med J (Clin Res Ed) 1985 Nov 2;291(6504):1256–1257. doi: 10.1136/bmj.291.6504.1256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Smith S. A., Dewhirst R. R. A simple diagnostic test for pupillary abnormality in diabetic autonomic neuropathy. Diabet Med. 1986 Jan;3(1):38–41. doi: 10.1111/j.1464-5491.1986.tb00703.x. [DOI] [PubMed] [Google Scholar]
  25. Sundkvist G., Lilja B., Almér L. O. Abnormal diastolic blood pressure and heart rate reactions to tilting in diabetes mellitus. Diabetologia. 1980 Nov;19(5):433–438. doi: 10.1007/BF00281822. [DOI] [PubMed] [Google Scholar]
  26. Thomas P. K. Metabolic neuropathy. J R Coll Physicians Lond. 1973 Jan;7(2):154–160. [PMC free article] [PubMed] [Google Scholar]
  27. White N. H., Gingerich R. L., Levandoski L. A., Cryer P. E., Santiago J. V. Plasma pancreatic polypeptide response to insulin-induced hypoglycemia as a marker for defective glucose counterregulation in insulin-dependent diabetes mellitus. Diabetes. 1985 Sep;34(9):870–875. doi: 10.2337/diab.34.9.870. [DOI] [PubMed] [Google Scholar]
  28. White N. H., Skor D. A., Cryer P. E., Levandoski L. A., Bier D. M., Santiago J. V. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med. 1983 Mar 3;308(9):485–491. doi: 10.1056/NEJM198303033080903. [DOI] [PubMed] [Google Scholar]
  29. White N. H., Skor D., Santiago J. V. Practical closed-loop insulin delivery. A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics. Ann Intern Med. 1982 Aug;97(2):210–213. doi: 10.7326/0003-4819-97-2-210. [DOI] [PubMed] [Google Scholar]
  30. Wilson D. E. Excessive insulin therapy: biochemical effects and clinical repercussions. Current concepts of counterregulation in type I diabetes. Ann Intern Med. 1983 Feb;98(2):219–227. doi: 10.7326/0003-4819-98-2-219. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES